Search

Presents news briefs on issues related to world public health as of February 25, 2006. Suspension called by the World Health Organization for the marketing and sales of artemisinin monotherapy for falciparum malaria; Inclusion of the 7-valent pneumococcal conjugate vaccine in the child immunization program of Great Britain.

The article discusses the treated cardiovascular disorder by intravenous soya oil emulsion.

The article presents an editorial comment on "Can Albuterol be Blamed for Lactic Acidosis?" by V.R. Dodda and colleagues.

This article reports on a paper by the World Allergy Organization confirming epinephrine as the drug of choice for anaphylaxis. The organization concludes that the benefit far exceeds the risk when it come to using appropriate doses of IM epinephrine [adrenaline] to treat anaphylaxis. It suggests that high-risk individuals should have an anaphylaxis action plan and carry epinephrine auto-injectors.

The article presents a case study of a 53-year-old woman who experienced restless leg syndrome while receiving quetiapine for type-2 bipolar manic disorder.

The article presents a case study of a 42-year-old man who developed ischaemic pontine stroke during treatment with quetiapine for bipolar depression.

The article discusses a study published in the June 2014 issue of "Pediatrics International" that identified an 8-year-old boy who developed acute disseminated encephalomyelitis (ADEM) following administration of influenza A virus vaccine-H1N1.

A review of a conference paper, "Cost-Effectiveness of Isoniazid Preventative Therapy for HIV Infected Pregnant Women in India" by Kapoor S, et al. presented at the 22nd Conference on Retroviruses and Opportunistic Infections held in Seattle from 23 to 25 February 2015 is presented.

The article presents a case study of the successful dosage of fondaparinux in a child with heparin-induced thrombocytopenia.

The article presents case studies of three chronic hepatitis C patients who developed inflammatory bowel disease after taking ribavirin and peginterferon.

The article presents a case study of a man with myelodysplastic syndrome who was treated with thalidomide, stanozolol, and deferoxamine, and developed acute interstitial pneumonia.

The article discusses a case study on three patients with chronic hepatitis C who developed inflammatory bowel disease after being treated with peginterferon and ribavirin.

The article presents abstracts on case reports related to adverse reactions of various drugs including abciximab, adalimumab and adenosine.

A case study of three women and one man, aged 22-68 years is presented who received either esomeprazole, omeprazole or pantoprazole and developed acute interstitial nephritis (AIN).

The article describes the cases of two patients who developed skin hyperpigmentation during treatment with minocycline for Chlamydia pneumoniae infection and acne vulgaris, respectively.

The article describes the case of a 16-year-old girl who developed opisthotonus during fluoxetine therapy for conversion disorder.

The article describes the case of a 29-year-old man who developed coronary artery intimal hyperplasia after receiving methylphenidate sumatriptan and amfetamine mixed salts.

A correction to the article "Acute interstitial nephritis secondary to long-term use of cetirizine for the treatment of urticaria pigmentosa" that was published in the January 2013 issue is presented.

This section cites the case of an elderly patient who developed toxic epidermal necrolysis following amiodarone therapy.

The article presents a case study of a 42-year-old man who developed hypogonadotropic hypogonadism while receiving fentanyl for severe pain.

The article presents case reports of two women who developed maculopapular eruption (MPE) and one woman who developed erythema multiforme (EM)-type drug eruption while being treated with lamotrigine.

The article discusses research on the cost-effectiveness of distributing naloxone to heroin users for overdose reversal, referencing a study by P. O. Coffin and colleagues, published in the January 1, 2013 issue of "Annals of Internal Medicine."

The article describes the case of a 60-year-old woman who developed encephalopathy while undergoing metronidazole therapy for anaerobic brain abscess.

The article cites a case of solitary pulmonary nodule mimicking lung cancer due to mineral oil ingestion.

The article describes the case of a male patient who experienced milt intermittent peripheral sensory neuropathy, mild transient post-infusion fatigue and mild cytopenias while receiving intravenous treatment with brentuximab vedotin for mycosis fungoides.

The article describes the case of a 60-year-old man who developed gynaecomastia while undergoing bicalutamide therapy for advanced prostate cancer.

The article describes the case of three men and two women aged 27-55 years with a history of invasive fungal infections (IFI) who developed acute kidney injury (AKI) while receiving amphotericin B liposomal for haematological malignancy.

The article describes the case of a 63-year-old postmenopausal woman who suffered from multiple intracranial meningiomas after undergoing long-term megestrol therapy for breast cancer.

The article describes the case of an 85-year-old woman who experienced respiratory dyskinesia while taking levodopa for a Parkinson-like tremor.

The article reports that a Health Canada-endorsed letter has been issued by Ferring Pharmaceuticals, advising that all intranasal desmopressin formulations are no longer indicated for the treatment of primary nocturnal enuresis (PNE) because of increased risk of hyponatraemia. Ferring has advised healthcare professionals to only prescribe an oral formulation to new patients treated for PNE. Desmopressin formulations include DDAVP spray and DDAVP Rhinyle Solution.

The article focuses on a study comparing the effectiveness of polythylene glycol laxative and placebo for relief of constipation from constipating medications by J. A. DiPalma et al. in the November 2007 issue of the "Southern Medical Journal." It found that polyethylene glycol (PEG) 3350 is effective for constipated patients who are receiving medications linked to inducing constipation. It notes that the clinical trial administered placebo to participants. The study also showed better mean weekly number of bowel movements.

The article focuses on the recommended medical treatments by the British National Institute of Clinical Excellence (NICE) based on its consultation papers published on May 30 and June 4, 2007. NICE has recommended multiple myeloma patients with a full or partial response to bortezomib to continue such treatment. It also approved the use of varenicline as an optional treatment for adults who wish to quit smoking.

Information about several papers discussed at the 2007 Annual Meeting of the American Academy of Dermatology. Three posters presented a number of studies that support the use of topical desonide and a hydrogen vehicle in treating atopic dermatitis. A phase IV clinical trial revealed that the combination of topical diclofenac and cryosurgery is more effective in actinic keratosis than diclofenac of cryosurgery alone.

The article presents findings of meta-analyses related to the correlation between rofecoxib use and increased risks of adverse cardiovascular (CV) events, renal events and arrhythmia. A comparison of the risks of serious CV events with cyclooxygenase 2 (COX-2) inhibitors and individual non-steroidal anti-inflammatory agents is provided. The risks for renal events and arrhythmia events associated with COX-2 inhibitors are discussed.

The article provides information on the results of a post-hoc analysis of the Treating to New Targets study regarding the use of atorvastatin in metabolic syndrome. It says that patients had a significantly higher cardiovascular risk than patients with coronary artery disease without metabolic syndrome in the presence of low-dose atorvastatin therapy.

Presents news briefs concerning the approval of drugs as of February 28, 2004. Therapeutic approval given to octocog alfa of Baxter AG; Authorization for marketing the antimalarial drug voacamine of Millenia Hope.

This section offers news briefs on therapeutics as of January 2008. A study cites the superiority of bortezomib over high-dose dexamethasone in patients with relapsed multiple myeloma (MM). Another research found the benefits of eculizumab in reducing the risk of thromboembolism in patients with paroxysmal nocturnal haemoglobinuria (PNH). A study shows the effectiveness of topiramate in preventing migraine attacks.

Provides an overview of several studies related to therapeutics. Feasibility of intracoronary infusion of granulocyte colony-stimulating factor mobilized cells; Effectiveness of oral tazarotene in the treatment of psoriasis; Comparison of the effectiveness of omapatrilat and enalapril in the treatment of hypertensive patients.

The article describes the case of a 45-year-old man who developed akathisia following metoclopramide administration for contracture release and split skin grafting.

The article describes the cases of 11 patients who developed endophthalmitis and uveitis following separate administration of pegaptanib, ranibizumab and triamcinolone.

The article describes the case of a 19-year-old woman with cystic fibrosis who developed type 1 hypersensitivity while receiving treatment with aztreonam.

An abstract of the article "Successful treatment of adult patients with idiopathic recurrent pericarditis with an interleukin-1 receptor antagonist (anakinra)," by D. Vassilopoulos and colleagues is presented.

The article describes the case of a 50-year-old woman who developed an allergic reaction while receiving oxaliplatin for advanced colon cancer with peritoneal dissemination.

The article describes the case of a 56-year-old woman who developed diffuse alveolar haemorrhage (DAH) and acute respiratory distress syndrome while undergoing etanercept therapy for rheumatic and psoriatic arthritis.

The article describes the case of a 57-year-old with human immunodeficiency virus (HIV) infection who experienced reactivation of a latent hepatitis B virus (HBV) infection while receiving treatment with glucocorticoid receptor agonists and ritonavir.

The article describes the case of a 47-year-old male patient who experienced akathisia while undergoing treatment with bromopride and fluvoxamine.

The article describes the case of a 68-year-old male patient who experienced leg paraesthesia after undergoing bortezomib therapy for amyloid light-chain amyloidosis.

The article presents a case study of a 27-year-old man with a long history of schizoaffective disorder with recent suicidal ideation who ingested 42 extended-release capsules of venlafaxine 150 milligrams and developed pulmonary eosinophilia.